Publicaciones en colaboración con investigadores/as de Universidad de Sevilla (13)

2024

  1. Correction to: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial (Nature Communications, (2024), 15, 1, (5251), 10.1038/s41467-024-49121-3)

    Nature Communications

  2. Correction to: dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe (Nature Communications, (2024), 15, 1, (3736), 10.1038/s41467-024-47751-1)

    Nature Communications

  3. Formulation of protein-loaded nanoparticles via freeze-drying

    Drug Delivery and Translational Research

  4. dsRNAi-mediated silencing of PIAS2beta specifically kills anaplastic carcinomas by mitotic catastrophe

    Nature Communications, Vol. 15, Núm. 1

2023

  1. Effectiveness and Safety of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes Previously Treated with Continuous Subcutaneous Insulin Infusion and Flash Glucose Monitoring

    Diabetes technology & therapeutics, Vol. 25, Núm. 2, pp. 151-156

  2. Executive summary of the expert consensus document from the Spanish Society of Neurosurgery and the Spanish Society of Endocrinology and Nutrition: Clinical recommendations on the perioperative management of pituitary tumors

    Neurocirugia, Vol. 34, Núm. 6, pp. 292-307

  3. Executive summary of the expert consensus document from the Spanish Society of Neurosurgery and the Spanish Society of Endocrinology and Nutrition: Clinical recommendations on the perioperative management of pituitary tumors

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 9, pp. 592-608

  4. Successful Use of an Advanced Hybrid Closed-loop System in a Patient With Type 3c Pancreatogenic Diabetes Secondary to Nesidioblastosis

    Canadian Journal of Diabetes, Vol. 47, Núm. 2, pp. 193-196

2022

  1. Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia

    Journal of Clinical Medicine, Vol. 11, Núm. 4

2014

  1. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF

    Endocrinology, Vol. 155, Núm. 11, pp. 4329-4340

2005

  1. Consensus guidelines on screening for hypopituitarism following traumatic brain injury

    Brain Injury, Vol. 19, Núm. 9, pp. 711-724

  2. Erratum: Hypopituitarism following traumatic brain injury (TBI): A guideline Decalogue (Journal of Endocrinological Investigation (2004) 27, 8 (793))

    Journal of Endocrinological Investigation

2004

  1. Hypopituitarism following traumatic brain injury (TBI): A guideline decalogue

    Journal of Endocrinological Investigation, Vol. 27, Núm. 8, pp. 793-795